Craig R. Stapleton is Director at AVADEL PHARMACEUTICALS PLC (AVDL). They have made 12 open-market trades across 3 companies since 2016, most recently 2017-12-15.
CIK 0001012477
11 open-market purchases totalling $3.6M since 2016, against 1 sale. Across 10 scored buys the stock is down 10.8% at ninety days, and 13.1 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 55% | 10% |
| Avg Move | +0.7% | +1.6% | -10.8% |
| Alpha | +0.8% | +0.8% | -13.1% |
| Scored | 11 | 11 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVDL | BUY | 2017-12-15 | 2017-12-19 | $8.67 | $607K | +3.5% | +25.8% | -17.8% |
| AVDL | SELL | 2017-11-27 | 2017-11-29 | $9.35 | $2.4M | -5.5% | -13.4% | -12.5% |
| AVDL | BUY | 2017-09-12 | 2017-09-14 | $9.52 | $190K | -0.7% | +5.4% | -10.0% |
| AVDL | BUY | 2017-05-18 | 2017-05-22 | $9.85 | $305K | +5.2% | +11.2% | -10.0% |
| AVDL | BUY | 2017-05-18 | 2017-05-22 | $9.98 | $110K | +5.2% | +11.2% | -10.0% |
| FLML | BUY | 2016-11-28 | 2016-11-30 | $10.80 | $216K | -2.6% | -4.2% | N/A |
| ANF | BUY | 2016-09-01 | 2016-09-06 | $17.65 | $177K | +1.0% | -7.4% | -13.6% |
| FLML | BUY | 2016-09-01 | 2016-09-06 | $13.52 | $135K | -4.4% | -11.2% | -25.4% |
| FLML | BUY | 2016-08-26 | 2016-08-29 | $13.76 | $275K | -5.1% | -9.9% | -25.1% |
| FLML | BUY | 2016-08-26 | 2016-08-29 | $13.76 | $275K | -5.1% | -9.9% | -25.1% |
| FLML | BUY | 2016-05-13 | 2016-05-16 | $9.21 | $229K | +11.5% | +2.1% | +38.1% |
| FLML | BUY | 2016-03-14 | 2016-03-16 | $10.39 | $1.0M | -0.6% | +4.9% | -9.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.